This compansy' shares have crashed 77 percent YTD. Consolidation may offer a new entry opportunity for this restructuring drug company. It is highly unlikely to go bankrupt. The drug company reaffirmed its revenue guidance as part of its 2nd quarter earnings release, and guided for significant debt reductions on the back of asset sales and free cash flow. Further, its new Chief Executive Officer put $8 billion of non core asset sales on the table in order to pay down the drug company's debt.
Drug company Valeant Pharmaceuticals International, Inc. (NYSE:VRX) was the most exciting story in the stock market of 2015/6 if you ask me. Unfortunately, shareholders of Valeant Pharmaceuticals that bought into the acquisition model a year ago are now sitting on devastating losses. I can only say congrats to all those investors that jumped off the sinking ship in time last year, and those investors that actually shorted the drug company.
Source: Seeking Alpha
Related Articles:
- 7 Undervalued, Big-Name Stocks To Consider For Your Dividend Portfolio
- 7 High-Yield Energy Stocks Growing Their Dividends
- 5 Dividend Stocks In Need Of A Market Correction
- 10 Dividend Stocks Building A Growing Cash Stream
- How To Build A Sustainable High Yield Portfolio
________________________________________________________________
Subscribe to:
Post Comments (Atom)
Popular Posts Last 30 Days
-
Showing resilience during a tough week was a group of stocks that has not been heard from much in the past two years. A group that has been ...
-
The World Cup format brings in 32 teams from around the globe who square off until only one remains. After the first round, 16 teams are eli...
-
Legendary investor Warren Buffett is known for earning huge returns for his company Berkshire Hathaway Inc. (NYSE:BRK.B) and its shareholder...
-
The Holy Grail for income investors is finding quality companies with significant payouts that will continue to generate income over the lon...
-
In a bloated stock market, going after the hottest tickers won’t get you much in terms of yield. That’s why, for investors looking to boost ...
-
While growth stocks grab all the headlines and generate all the hype, dividend-paying stocks have handily outperformed their nonpaying peers...
-
Is it possible to double your money – quickly – buying safe dividend stocks? You bet. Let me explain how… “Basic” income investors are enamo...
-
There's been a lot for investors to like about market performance over the last decade, but there's a flip side: In a market that cl...
-
There is no other way to put it: The U.S. stock market seems to be losing its momentum. Year-to-date, the market has been trading mostly sid...
-
All four of these names have very strong cash flows that allow them to not only pay better than 3% dividends, but also to buy back stock. Tw...
0 comments
Post a Comment
Post a Comment